Study directory

Mental health studies with practical context.

Public study records, presented in a clearer and more patient-friendly format for mental health research discovery.

Back to overview
23847studies shown
Showing 16,417-16,428 of 23,847
Drug study icon
CompletedNCT01104792

Long-term Study of Cariprazine in people with Schizophrenia

This summary needs review. Please check the official study record and contact the research team for details.

Multiple locations, including Little Rock
SchizophreniaDrugA study involving a medication or substance.From 18 Years to 60 Years
Countries
United States, Colombia, India, ...
Sponsor
Forest Laboratories
Condition
Schizophrenia
Drug study icon
CompletedNCT02335658

Long-term Study of DSP-5423P in people with Schizophrenia

This study exists to better understand the safety of the medication DSP-5423P and how manageable it feels in practice. For people living with Schizophrenia, that matters because care needs to work in daily life, not just in theory.

In Tokyo
SchizophreniaDrugOver 18 Years
Countries
Japan
Sponsor
Sumitomo Pharma Co., Ltd.
Condition
Schizophrenia
Drug study icon
CompletedNCT01737268

Long-term Study of FK949E in Elderly Bipolarity Patients

This study exists to understand whether the medication FK949E is both safe enough and useful enough to take further. Researchers are trying to understand how people respond to the medication FK949E in practice and what may need to be adjusted.

Multiple locations, including Chiba
BipolarityDrugOver 65 Years
Countries
Japan
Sponsor
Astellas Pharma Inc
Condition
Bipolarity
Drug study icon
CompletedNCT01626872

Long-Term Study of MP-214 in people with Schizophrenia

This study exists to understand how the medication MP-214 holds up over time after the earliest research stage. For people living with Schizophrenia, that matters because care needs to work in daily life, not just in theory.

Multiple locations, including Sapporo
SchizophreniaDrugFrom 20 Years to 65 Years
Countries
Japan, South Korea, Taiwan
Sponsor
Tanabe Pharma Corporation
Condition
Schizophrenia
Drug study icon
CompletedNCT00190684

Long-Term, Open Label Atomoxetine Study

This summary needs review. Please check the official study record and contact the research team for details.

Multiple locations, including Birmingham
ADHDDrugFrom 6 Years to 18 Years
Countries
United States, Australia, France, ...
Sponsor
Eli Lilly and Company
Condition
ADHD
Drug study icon
TerminatedNCT02893371

Longitudinal Comparative Effectiveness of Bipolarity Therapies

This study exists to learn from real-world information that can show how a digital app or remote support tool fits into care. Researchers are trying to understand whether a digital app or remote support tool can better prevent setbacks and support longer-term stability.

In Albuquerque
BipolarityDrug
Countries
United States
Sponsor
University of New Mexico
Condition
Bipolarity
Device study icon
UnknownNCT06233422

Longitudinal Ecological Study on Sleep-Wake Patterns in MDD Using Actigraphy

This observational study is following people with Depression or Sleep Disorders, Circadian Rhythm to understand outcomes over time. Participants are followed over time so researchers can learn from clinical and follow-up information.

In Shatin
DepressionOtherFrom 18 Years to 65 Years
Countries
China
Sponsor
Chinese University of Hong Kong
Condition
Depression
Data coverage

Public registry coverage is progressing

HopeStage gathers information about mental health clinical trials from the public registries we currently index. We are progressively improving registry coverage, but this does not mean that every study in the world is already included.